Switch Language

News

Please find below the last exciting news from GSV & Life Sciences Sector.

Save the date – Genève sciences de la vie

Mercredi 6 novembre 2019 – 17h00
FER Genève – 98, rue de Saint Jean – 1201 Genève

L’association Genève Sciences de la Vie a le plaisir de vous convier à fêter ses 70 ans
pour une soirée de réflexion sur le passé, le présent et le futur des sciences de la vie.

Avec la participation de:
Pierre Maudet, Conseiller d’État.
Luc Ferry, écrivain et philosophe.
Geneviève Berger, médecin et biophysicienne,
Directrice du département R&D du groupe Firmenich.

Table ronde animée par Benoît Dubuis.

June 14, 2019

Lumendi reports its first 'incisionless appendectomy' procedure

<span property="schema:name">Lumendi reports its first 'incisionless appendectomy' procedure</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-06-02T15:14:04+00:00">Tue, 06/02/2020 - 11:14</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/lumendi-reports-its-first-incisionless-appendectomy-procedure" data-a2a-title="Lumendi reports its first 'incisionless appendectomy' procedure"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Flumendi-reports-its-first-incisionless-appendectomy-procedure&title=Lumendi%20reports%20its%20first%20%26%23039%3Bincisionless%20appendectomy%26%23039%3B%20procedure"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center

<span property="schema:name">In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-02T12:53:38+00:00">Tue, 06/02/2020 - 08:53</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/conversation-tom-lynch-president-and-director-fred-hutchinson-cancer-research" data-a2a-title="In conversation with Tom Lynch, president and director of Fred Hutchinson Cancer Research Center"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fconversation-tom-lynch-president-and-director-fred-hutchinson-cancer-research&title=In%20conversation%20with%20Tom%20Lynch%2C%20president%20and%20director%20of%20Fred%20Hutchinson%20Cancer%20Research%20Center"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority

<span property="schema:name">Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/39341" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">ntaylor</span></span>
<span property="schema:dateCreated" content="2020-06-02T12:22:14+00:00">Tue, 06/02/2020 - 08:22</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/hahn-permanently-adopting-r-d-accelerating-covid-19-measures-a-top-fda-priority" data-a2a-title="Hahn: Permanently adopting R&D-accelerating COVID-19 measures is a top FDA priority"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fhahn-permanently-adopting-r-d-accelerating-covid-19-measures-a-top-fda-priority&title=Hahn%3A%20Permanently%20adopting%20R%26amp%3BD-accelerating%20COVID-19%20measures%20is%20a%20top%20FDA%20priority"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis

<span property="schema:name">Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-02T11:07:16+00:00">Tue, 06/02/2020 - 07:07</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/pfizer-to-funnel-500m-into-biotechs-offering-crucial-capital-during-covid-crisis" data-a2a-title="Pfizer to funnel $500M into biotechs, offering 'crucial capital' during the COVID-19 crisis"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fpfizer-to-funnel-500m-into-biotechs-offering-crucial-capital-during-covid-crisis&title=Pfizer%20to%20funnel%20%24500M%20into%20biotechs%2C%20offering%20%26%23039%3Bcrucial%20capital%26%23039%3B%20during%20the%20COVID-19%20crisis"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs

<span property="schema:name">Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-02T08:33:48+00:00">Tue, 06/02/2020 - 04:33</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/stanford-researcher-mark-genovese-joins-gilead-to-lead-nash-arthritis-programs" data-a2a-title="Stanford researcher Genovese joins Gilead to lead NASH, arthritis programs"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fstanford-researcher-mark-genovese-joins-gilead-to-lead-nash-arthritis-programs&title=Stanford%20researcher%20Genovese%20joins%20Gilead%20to%20lead%20NASH%2C%20arthritis%20programs"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

Hillhouse leads $160M round for Chinese antibody maker Genor

<span property="schema:name">Hillhouse leads $160M round for Chinese antibody maker Genor</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40211" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">aalidrus</span></span>
<span property="schema:dateCreated" content="2020-06-02T13:28:40+00:00">Tue, 06/02/2020 - 09:28</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/hillhouse-leads-160m-round-for-chinese-antibody-maker-genor" data-a2a-title="Hillhouse leads $160M round for Chinese antibody maker Genor"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fhillhouse-leads-160m-round-for-chinese-antibody-maker-genor&title=Hillhouse%20leads%20%24160M%20round%20for%20Chinese%20antibody%20maker%20Genor"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 02, 2020

Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost

<span property="schema:name">Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost </span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-01T11:56:29+00:00">Mon, 06/01/2020 - 07:56</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/regeneron-boosts-intellia-crispr-pact-bleeding-disorder-focus-cash-boost" data-a2a-title="Regeneron boosts Intellia CRISPR pact with bleeding disorder focus, cash boost "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fregeneron-boosts-intellia-crispr-pact-bleeding-disorder-focus-cash-boost&title=Regeneron%20boosts%20Intellia%20CRISPR%20pact%20with%20bleeding%20disorder%20focus%2C%20cash%20boost%20"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action

<span property="schema:name">Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-01T10:40:14+00:00">Mon, 06/01/2020 - 06:40</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/biotech-ipo-bonanza-legend-s-350m-offering-as-repare-forma-get-action" data-a2a-title="Biotech IPO bonanza: Legend's $350M offering as Repare, Forma get in on the action"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fbiotech-ipo-bonanza-legend-s-350m-offering-as-repare-forma-get-action&title=Biotech%20IPO%20bonanza%3A%20Legend%26%23039%3Bs%20%24350M%20offering%20as%20Repare%2C%20Forma%20get%20in%20on%20the%20action"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

AbbVie pens cancer pact with U.S.-China biotech Jacobio

<span property="schema:name">AbbVie pens cancer pact with U.S.-China biotech Jacobio</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-06-01T11:28:07+00:00">Mon, 06/01/2020 - 07:28</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/abbvie-pens-cancer-pact-u-s-china-biotech-jacobio-pharma" data-a2a-title="AbbVie pens cancer pact with U.S.-China biotech Jacobio"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fabbvie-pens-cancer-pact-u-s-china-biotech-jacobio-pharma&title=AbbVie%20pens%20cancer%20pact%20with%20U.S.-China%20biotech%20Jacobio"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Lilly starts first clinical trial of COVID-19 antibody therapy

<span property="schema:name">Lilly starts first clinical trial of COVID-19 antibody therapy</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/39341" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">ntaylor</span></span>
<span property="schema:dateCreated" content="2020-06-01T12:12:32+00:00">Mon, 06/01/2020 - 08:12</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/lilly-starts-first-clinical-trial-covid-19-antibody-therapy" data-a2a-title="Lilly starts first clinical trial of COVID-19 antibody therapy"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Flilly-starts-first-clinical-trial-covid-19-antibody-therapy&title=Lilly%20starts%20first%20clinical%20trial%20of%20COVID-19%20antibody%20therapy"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Antibe's NSAID alternative curbs arthritis pain in phase 2

<span property="schema:name">Antibe's NSAID alternative curbs arthritis pain in phase 2</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40211" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">aalidrus</span></span>
<span property="schema:dateCreated" content="2020-06-01T13:26:23+00:00">Mon, 06/01/2020 - 09:26</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/antibe-s-nsaid-alternative-curbs-arthritis-pain-phase-2" data-a2a-title="Antibe's NSAID alternative curbs arthritis pain in phase 2"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fantibe-s-nsaid-alternative-curbs-arthritis-pain-phase-2&title=Antibe%26%23039%3Bs%20NSAID%20alternative%20curbs%20arthritis%20pain%20in%20phase%202"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm

<span property="schema:name">I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/45406" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">arlene.weintraub</span></span>
<span property="schema:dateCreated" content="2020-06-01T13:29:34+00:00">Mon, 06/01/2020 - 09:29</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/research/i-mab-advances-repositioned-ra-drug-early-trial-to-treat-covid-19-cytokine-storm" data-a2a-title="I-MAB advances repositioned RA drug in early trial to treat COVID-19 cytokine storm"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fresearch%2Fi-mab-advances-repositioned-ra-drug-early-trial-to-treat-covid-19-cytokine-storm&title=I-MAB%20advances%20repositioned%20RA%20drug%20in%20early%20trial%20to%20treat%20COVID-19%20cytokine%20storm"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Abiomed gets Impella pump EUA for coronavirus-related heart failure

<span property="schema:name">Abiomed gets Impella pump EUA for coronavirus-related heart failure</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-06-01T14:34:35+00:00">Mon, 06/01/2020 - 10:34</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/abiomed-gets-impella-pump-eua-for-coronavirus-related-heart-failure" data-a2a-title="Abiomed gets Impella pump EUA for coronavirus-related heart failure"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fabiomed-gets-impella-pump-eua-for-coronavirus-related-heart-failure&title=Abiomed%20gets%20Impella%20pump%20EUA%20for%20coronavirus-related%20heart%20failure"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Sema4 partners with Connecticut to assist state COVID-19 testing

<span property="schema:name">Sema4 partners with Connecticut to assist state COVID-19 testing</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-06-01T15:20:20+00:00">Mon, 06/01/2020 - 11:20</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/sema4-partners-connecticut-to-assist-state-covid-19-testing" data-a2a-title="Sema4 partners with Connecticut to assist state COVID-19 testing"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fsema4-partners-connecticut-to-assist-state-covid-19-testing&title=Sema4%20partners%20with%20Connecticut%20to%20assist%20state%20COVID-19%20testing"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

June 01, 2020

Survey details shortages of COVID-19 testing supplies and labs' responses

<span property="schema:name">Survey details shortages of COVID-19 testing supplies and labs' responses</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-05-31T22:12:19+00:00">Sun, 05/31/2020 - 18:12</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/survey-details-shortages-covid-19-testing-supplies-and-labs-responses" data-a2a-title="Survey details shortages of COVID-19 testing supplies and labs' responses"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Fsurvey-details-shortages-covid-19-testing-supplies-and-labs-responses&title=Survey%20details%20shortages%20of%20COVID-19%20testing%20supplies%20and%20labs%26%23039%3B%20responses"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 31, 2020

FDA greenlights Quest, LetsGetChecked home-based coronavirus tests

<span property="schema:name">FDA greenlights Quest, LetsGetChecked home-based coronavirus tests</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-05-31T20:51:49+00:00">Sun, 05/31/2020 - 16:51</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/fda-greenlights-quest-letsgetchecked-home-based-coronavirus-tests" data-a2a-title="FDA greenlights Quest, LetsGetChecked home-based coronavirus tests"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Ffda-greenlights-quest-letsgetchecked-home-based-coronavirus-tests&title=FDA%20greenlights%20Quest%2C%20LetsGetChecked%20home-based%20coronavirus%20tests"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 31, 2020

Ipsen names Sanofi Pasteur CEO Loew as new leader

<span property="schema:name">Ipsen names Sanofi Pasteur CEO Loew as new leader</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/39341" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">ntaylor</span></span>
<span property="schema:dateCreated" content="2020-05-29T08:12:21+00:00">Fri, 05/29/2020 - 04:12</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/ipsen-names-sanofi-pasteur-ceo-loew-as-new-leader" data-a2a-title="Ipsen names Sanofi Pasteur CEO Loew as new leader"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fipsen-names-sanofi-pasteur-ceo-loew-as-new-leader&title=Ipsen%20names%20Sanofi%20Pasteur%20CEO%20Loew%20as%20new%20leader"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

ASCO: Myovant details speedy effects of prostate cancer med relugolix

<span property="schema:name">ASCO: Myovant details speedy effects of prostate cancer med relugolix</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40211" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">aalidrus</span></span>
<span property="schema:dateCreated" content="2020-05-29T00:46:55+00:00">Thu, 05/28/2020 - 20:46</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/asco-myovant-details-prostate-cancer-data-for-triple-threat-relugolix" data-a2a-title="ASCO: Myovant details speedy effects of prostate cancer med relugolix"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fasco-myovant-details-prostate-cancer-data-for-triple-threat-relugolix&title=ASCO%3A%20Myovant%20details%20speedy%20effects%20of%20prostate%20cancer%20med%20relugolix"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

ASCO: Ziopharm's IL-12 gene therapy boosts survival in hard-to-treat brain cancer

<span property="schema:name">ASCO: Ziopharm's IL-12 gene therapy boosts survival in hard-to-treat brain cancer</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40211" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">aalidrus</span></span>
<span property="schema:dateCreated" content="2020-05-29T03:27:36+00:00">Thu, 05/28/2020 - 23:27</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/asco-ziopharm-s-il-12-gene-therapy-boosts-survival-hard-to-treat-brain-cancer" data-a2a-title="ASCO: Ziopharm's IL-12 gene therapy boosts survival in hard-to-treat brain cancer"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fasco-ziopharm-s-il-12-gene-therapy-boosts-survival-hard-to-treat-brain-cancer&title=ASCO%3A%20Ziopharm%26%23039%3Bs%20IL-12%20gene%20therapy%20boosts%20survival%20in%20hard-to-treat%20brain%20cancer"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October

<span property="schema:name">COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October </span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-05-29T08:08:26+00:00">Fri, 05/29/2020 - 04:08</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/covid-19-vaccine-leaders-talk-up-need-for-partners-potential-for-a-working-vax-by-october" data-a2a-title="COVID-19 vaccine leaders talk up the need for partners, potential for a working vax by October "><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Fcovid-19-vaccine-leaders-talk-up-need-for-partners-potential-for-a-working-vax-by-october&title=COVID-19%20vaccine%20leaders%20talk%20up%20the%20need%20for%20partners%2C%20potential%20for%20a%20working%20vax%20by%20October%20"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

FDA approves Eli Lilly's Tauvid dye, its first for mapping Alzheimer's tau tangles

<span property="schema:name">FDA approves Eli Lilly's Tauvid dye, its first for mapping Alzheimer's tau tangles</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-05-29T14:47:56+00:00">Fri, 05/29/2020 - 10:47</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/fda-approves-eli-lilly-s-tauvid-dye-its-first-for-mapping-alzheimer-s-tau-tangles" data-a2a-title="FDA approves Eli Lilly's Tauvid dye, its first for mapping Alzheimer's tau tangles"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Ffda-approves-eli-lilly-s-tauvid-dye-its-first-for-mapping-alzheimer-s-tau-tangles&title=FDA%20approves%20Eli%20Lilly%26%23039%3Bs%20Tauvid%20dye%2C%20its%20first%20for%20mapping%20Alzheimer%26%23039%3Bs%20tau%20tangles"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

Amid pandemic, LabCorp's CRO unit Covance pens decentralized trials pact with Medable

<span property="schema:name">Amid pandemic, LabCorp's CRO unit Covance pens decentralized trials pact with Medable</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-05-29T09:49:00+00:00">Fri, 05/29/2020 - 05:49</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/cro/amid-pandemic-labcorp-s-cro-unit-covance-pens-decentralized-pact-medable" data-a2a-title="Amid pandemic, LabCorp's CRO unit Covance pens decentralized trials pact with Medable"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fcro%2Famid-pandemic-labcorp-s-cro-unit-covance-pens-decentralized-pact-medable&title=Amid%20pandemic%2C%20LabCorp%26%23039%3Bs%20CRO%20unit%20Covance%20pens%20decentralized%20trials%20pact%20with%20Medable"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

Takeda culls Shire pipeline med after no one wants it

<span property="schema:name">Takeda culls Shire pipeline med after no one wants it</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/40596" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">badams</span></span>
<span property="schema:dateCreated" content="2020-05-29T11:06:30+00:00">Fri, 05/29/2020 - 07:06</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/biotech/takeda-doesn-t-have-to-divest-shire-pipeline-med-as-no-one-wants-it-so-it-tosses-it-out" data-a2a-title="Takeda culls Shire pipeline med after no one wants it"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fbiotech%2Ftakeda-doesn-t-have-to-divest-shire-pipeline-med-as-no-one-wants-it-so-it-tosses-it-out&title=Takeda%20culls%20Shire%20pipeline%20med%20after%20no%20one%20wants%20it"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma

<span property="schema:name">ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/45406" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">arlene.weintraub</span></span>
<span property="schema:dateCreated" content="2020-05-29T12:56:34+00:00">Fri, 05/29/2020 - 08:56</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/research/asco-allogene-reports-63-response-rate-early-trial-off-shelf-car-t-lymphoma" data-a2a-title="ASCO: Allogene reports 63% response rate in early trial of off-the-shelf CAR-T in lymphoma"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fresearch%2Fasco-allogene-reports-63-response-rate-early-trial-off-shelf-car-t-lymphoma&title=ASCO%3A%20Allogene%20reports%2063%25%20response%20rate%20in%20early%20trial%20of%20off-the-shelf%20CAR-T%20in%20lymphoma"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

Univ. of Maryland researchers develop 'naked eye' COVID-19 test

<span property="schema:name">Univ. of Maryland researchers develop 'naked eye' COVID-19 test</span>
<span rel="schema:author"><span lang="" about="https://www.fiercebiotech.com/user/48481" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">chale</span></span>
<span property="schema:dateCreated" content="2020-05-29T15:32:24+00:00">Fri, 05/29/2020 - 11:32</span>
<span class="a2a_kit a2a_kit_size_32 addtoany_list" data-a2a-url="https://www.fiercebiotech.com/medtech/univ-maryland-researchers-develop-naked-eye-covid-19-test" data-a2a-title="Univ. of Maryland researchers develop 'naked eye' COVID-19 test"><a class="a2a_dd addtoany_share_save" href="https://www.addtoany.com/share#url=https%3A%2F%2Fwww.fiercebiotech.com%2Fmedtech%2Funiv-maryland-researchers-develop-naked-eye-covid-19-test&title=Univ.%20of%20Maryland%20researchers%20develop%20%26%23039%3Bnaked%20eye%26%23039%3B%20COVID-19%20test"></a><a class="a2a_button_facebook"></a>
<a class="a2a_button_twitter"></a>
<a class="a2a_button_linkedin"></a>
<a class="a2a_button_email"></a>
<a class="a2a_button_print"></a></span>


More info

May 29, 2020

[Campus Biotech] La biotech GliaPharm lève 2 millions de francs

La biotech genevoise GliaPharm a conclu une levée de fonds de 2 millions de francs pour poursuivre...

More info

May 28, 2020

L’application SwissCovid doit convaincre pour être efficace

Relancer l’économie c’est aussi empêcher la propagation du Covid-19 en surveillant le virus, notamment par...

More info

May 28, 2020

[UniverCité] Un logiciel suisse déleste les commandes de leurs coûts inutiles

Installée l’an dernier à UniverCité – Renens, dans le cadre du programme MassChallenge, Genlots sort...

More info

May 28, 2020

Bourse : La plus grande offre d’actions du secteur pharmaceutique de l’histoire démarre avec Sanofi et Regeneron

Sanofi va lever 11,1 milliards de dollars (9,89 milliards d’euros) de la cession de 21,6...

More info

May 28, 2020

Plus de 28 milliards pour la formation et la recherche

La Confédération devrait subventionner la formation, la recherche et l’innovation (FRI) à hauteur de plus...

More info

May 28, 2020

Une fondation suisse pour aider financièrement l’OMS à long terme

Une entité suisse, la Fondation de l’OMS, veut aider à long terme l’institution avec des...

More info

May 28, 2020

La Suisse pourrait-elle devenir un leader de l’intelligence artificielle éthique?

Certaines technologies en plein essor, comme l’intelligence artificielle (IA), ne connaissent ni réglementation ni normes...

More info

May 28, 2020

UBS va investir plusieurs centaines de millions dans les start-up fintech

Sous la conduite de son CIO Mike Dargan, UBS compte lancer son propre fonds pour...

More info

May 28, 2020

These are the best picks in the market-beating biotech sector, according to Credit Suisse

Biotechnology stocks have been a bright spot in the market during the coronavirus downturn, and...

More info

May 28, 2020

Rançongiciels: les criminels s’attaquent à la santé

Outre les demandes de chantage contre rançon, de très nombreuses attaques par hameçonnage (phishing) ont...

More info

May 28, 2020